The danger signal S100B integrates pathogen- and danger-sensing pathways to restrain inflammation

PLoS Pathogens

Volumn 7, Issue 3, 2011, Pages

  Sorci, Guglielmo ^a   Giovannini, Gloria ^a   Riuzzi, Francesca ^a   Bonifazi, Pierluigi ^a   Zelante, Teresa ^a   Zagarella, Silvia ^a   Bistoni, Francesco ^a   Donato, Rosario ^a   Romani, Luigina ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CALGRANULIN A; CALGRANULIN B; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYELOID DIFFERENTIATION FACTOR 88; NUCLEIC ACID; PROTEIN S100B; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; IMMUNOGLOBULIN RECEPTOR; NERVE GROWTH FACTOR; PROTEIN S 100; S 100 CALCIUM BINDING PROTEIN BETA SUBUNIT; S-100 CALCIUM-BINDING PROTEIN BETA SUBUNIT; TLR2 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DAMAGE ASSOCIATED MOLECULAR PATTERN; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; INFECTION; INFLAMMATION; LUNG ASPERGILLOSIS; MOLECULAR DYNAMICS; MOUSE; NEUTROPHIL; NONHUMAN; NUCLEOTIDE SEQUENCE; PARACRINE SIGNALING; PROTEIN EXPRESSION; ANIMAL; ASPERGILLUS; DISEASE MODEL; DRUG ANTAGONISM; HOST PATHOGEN INTERACTION; LUNG; METABOLISM; MICROBIOLOGY; MOUSE MUTANT; PATHOGENICITY; PHYSIOLOGY;

ASPERGILLUS;

ANIMALS; ASPERGILLUS; DISEASE MODELS, ANIMAL; HOST-PATHOGEN INTERACTIONS; LUNG; MICE; MICE, KNOCKOUT; NERVE GROWTH FACTORS; PULMONARY ASPERGILLOSIS; RECEPTORS, IMMUNOLOGIC; S100 PROTEINS; TOLL-LIKE RECEPTOR 2;

EID: 79953281711     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1001315     Document Type: Article

References (59)

1. Gallucci S, Matzinger P, (2001) Danger signals: SOS to the immune system. Curr Opin Immunol 13: 114-119.
2. Janeway CA Jr, Medzhitov R, (2002) Innate immune recognition. Annu Rev Immunol 20: 197-216.
3. Donato R, (2007) RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins. Curr Mol Med 7: 711-724.
4. Schmidt AM, Yan SD, Yan SF, Stern DM, (2001) The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 108: 949-955.
5. Sparvero LJ, Asafu-Adjei D, Kang R, Tang D, Amin N, et al. (2009) RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation. J Transl Med 7: 17.
6. Lin L, (2006) RAGE on the Toll Road? Cell Mol Immunol 3: 351-358.
7. O'Neill LA, (2006) How Toll-like receptors signal: what we know and what we don't know. Curr Opin Immunol 18: 3-9.
8. Chen GY, Tang J, Zheng P, Liu Y, (2009) CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. Science 323: 1722-1725.
9. Liu Y, Chen GY, Zheng P, (2009) CD24-Siglec G/10 discriminates danger- from pathogen-associated molecular patterns. Trends Immunol 30: 557-561.
10. Sitkovsky MV, Ohta A, (2005) The 'danger' sensors that STOP the immune response: the A2 adenosine receptors? Trends Immunol 26: 299-304.
11. Bianchi ME, (2009) HMGB1 loves company. J Leukoc Biol 86: 573-576.
12. Donato R, Sorci G, Riuzzi F, Arcuri C, Bianchi R, et al. (2009) S100B's double life: intracellular regulator and extracellular signal. Biochim Biophys Acta 1793: 1008-1022.
13. Gebhardt C, Riehl A, Durchdewald M, Nemeth J, Furstenberger G, et al. (2008) RAGE signaling sustains inflammation and promotes tumor development. J Exp Med 205: 275-285.
14. Kalea AZ, Reiniger N, Yang H, Arriero M, Schmidt AM, et al. (2009) Alternative splicing of the murine receptor for advanced glycation end-products (RAGE) gene. Faseb J 23: 1766-1774.
15. Leclerc E, Fritz G, Weibel M, Heizmann CW, Galichet A, (2007) S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains. J Biol Chem 282: 31317-31331.
16. Ostendorp T, Leclerc E, Galichet A, Koch M, Demling N, et al. (2007) Structural and functional insights into RAGE activation by multimeric S100B. Embo J 26: 3868-3878.
17. Leclerc E, Fritz G, Vetter SW, Heizmann CW, (2009) Binding of S100 proteins to RAGE: an update. Biochim Biophys Acta 1793: 993-1007.
18. Ivanov S, Dragoi AM, Wang X, Dallacosta C, Louten J, et al. (2007) A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. Blood 110: 1970-1981.
19. Tian J, Avalos AM, Mao SY, Chen B, Senthil K, et al. (2007) Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 8: 487-496.
20. Yanai H, Ban T, Wang Z, Choi MK, Kawamura T, et al. (2009) HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature 462: 99-103.
21. Clynes R, Moser B, Yan SF, Ramasamy R, Herold K, et al. (2007) Receptor for AGE (RAGE): weaving tangled webs within the inflammatory response. Curr Mol Med 7: 743-751.
22. van Zoelen MA, Schouten M, de Vos AF, Florquin S, Meijers JC, et al. (2009) The receptor for advanced glycation end products impairs host defense in pneumococcal pneumonia. J Immunol 182: 4349-4356.
23. Segal BH, (2009) Aspergillosis. N Engl J Med 360: 1870-1884.
24. Aimanianda V, Bayry J, Bozza S, Kniemeyer O, Perruccio K, et al. (2009) Surface hydrophobin prevents immune recognition of airborne fungal spores. Nature 460: 1117-1121.
25. Romani L, Fallarino F, De Luca A, Montagnoli C, D'Angelo C, et al. (2008) Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature 451: 211-215.
26. Chavakis T, Bierhaus A, Al-Fakhri N, Schneider D, Witte S, et al. (2003) The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J Exp Med 198: 1507-1515.
27. Manfredi AA, Capobianco A, Esposito A, De Cobelli F, Canu T, et al. (2008) Maturing dendritic cells depend on RAGE for in vivo homing to lymph nodes. J Immunol 180: 2270-2275.
28. Moser B, Desai DD, Downie MP, Chen Y, Yan SF, et al. (2007) Receptor for advanced glycation end products expression on T cells contributes to antigen-specific cellular expansion in vivo. J Immunol 179: 8051-8058.
29. Zelante T, De Luca A, Bonifazi P, Montagnoli C, Bozza S, et al. (2007) IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol 37: 2695-2706.
30. Bonifazi P, D'Angelo C, Zagarella S, Zelante T, Bozza S, et al. (2010) Intranasally delivered siRNA targeting PI3K/Akt/mTOR inflammatory pathways protects from aspergillosis. Mucosal Immunol 3: 193-205.
31. Donato R, (2003) Intracellular and extracellular roles of S100 proteins. Microsc Res Tech 60: 540-551.
32. Huttunen HJ, Kuja-Panula J, Sorci G, Agneletti AL, Donato R, et al. (2000) Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J Biol Chem 275: 40096-40105.
33. Hreggvidsdottir HS, Ostberg T, Wahamaa H, Schierbeck H, Aveberger AC, et al. (2009) The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation. J Leukoc Biol 86: 655-662.
34. Bellocchio S, Moretti S, Perruccio K, Fallarino F, Bozza S, et al. (2004) TLRs govern neutrophil activity in aspergillosis. J Immunol 173: 7406-7415.
35. Moretti S, Bellocchio S, Bonifazi P, Bozza S, Zelante T, et al. (2008) The contribution of PARs to inflammation and immunity to fungi. Mucosal Immunol 1: 156-168.
36. Sahay B, Patsey RL, Eggers CH, Salazar JC, Radolf JD, et al. (2009) CD14 signaling restrains chronic inflammation through induction of p38-MAPK/SOCS-dependent tolerance. PLoS Pathog 5: e1000687.
37. Sha Q, Truong-Tran AQ, Plitt JR, Beck LA, Schleimer RP, (2004) Activation of airway epithelial cells by toll-like receptor agonists. Am J Respir Cell Mol Biol 31: 358-364.
38. Bonizzi G, Karin M, (2004) The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25: 280-288.
39. Popovic PJ, DeMarco R, Lotze MT, Winikoff SE, Bartlett DL, et al. (2006) High mobility group B1 protein suppresses the human plasmacytoid dendritic cell response to TLR9 agonists. J Immunol 177: 8701-8707.
40. Collison KS, Parhar RS, Saleh SS, Meyer BF, Kwaasi AA, et al. (2002) RAGE-mediated neutrophil dysfunction is evoked by advanced glycation end products (AGEs). J Leukoc Biol 71: 433-444.
41. Chai LY, Kullberg BJ, Vonk AG, Warris A, Cambi A, et al. (2009) Modulation of Toll-like receptor 2 (TLR2) and TLR4 responses by Aspergillus fumigatus. Infect Immun 77: 2184-2192.
42. Bierhaus A, Humpert PM, Morcos M, Wendt T, Chavakis T, et al. (2005) Understanding RAGE, the receptor for advanced glycation end products. J Mol Med 83: 876-886.
43. Huttunen HJ, Fages C, Rauvala H, (1999) Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J Biol Chem 274: 19919-19924.
44. Adami C, Bianchi R, Pula G, Donato R, (2004) S100B-stimulated NO production by BV-2 microglia is independent of RAGE transducing activity but dependent on RAGE extracellular domain. Biochim Biophys Acta 1742: 169-177.
45. Kajava AV, Vasselon T, (2010) A network of hydrogen bonds on the surface of TLR2 controls ligand positioning and cell signaling. J Biol Chem pp. 6227-6234.
46. Heizmann CW, Fritz G, Schafer BW, (2002) S100 proteins: structure, functions and pathology. Front Biosci 7: d1356-1368.
47. Guiducci C, Ott G, Chan JH, Damon E, Calacsan C, et al. (2006) Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation. J Exp Med 203: 1999-2008.
48. Honda K, Ohba Y, Yanai H, Negishi H, Mizutani T, et al. (2005) Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 434: 1035-1040.
49. Ramirez-Ortiz ZG, Specht CA, Wang JP, Lee CK, Bartholomeu DC, et al. (2008) Toll-like receptor 9-dependent immune activation by unmethylated CpG motifs in Aspergillus fumigatus DNA. Infect Immun 76: 2123-2129.
50. Bozza S, Perruccio K, Montagnoli C, Gaziano R, Bellocchio S, et al. (2003) A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation. Blood 102: 3807-3814.
51. Kariko K, Ni H, Capodici J, Lamphier M, Weissman D, (2004) mRNA is an endogenous ligand for Toll-like receptor 3. J Biol Chem 279: 12542-12550.
52. Aksoy E, Zouain CS, Vanhoutte F, Fontaine J, Pavelka N, et al. (2005) Double-stranded RNAs from the helminth parasite Schistosoma activate TLR3 in dendritic cells. J Biol Chem 280: 277-283.
53. Cavassani KA, Ishii M, Wen H, Schaller MA, Lincoln PM, et al. (2008) TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events. J Exp Med 205: 2609-2621.
54. Castets F, Griffin WS, Marks A, Van Eldik LJ, (1997) Transcriptional regulation of the human S100 beta gene. Brain Res Mol Brain Res 46: 208-216.
55. Cai W, He JC, Zhu L, Lu C, Vlassara H, (2006) Advanced glycation end product (AGE) receptor 1 suppresses cell oxidant stress and activation signaling via EGF receptor. Proc Natl Acad Sci U S A 103: 13801-13806.
56. Vives V, Alonso G, Solal AC, Joubert D, Legraverend C, (2003) Visualization of S100B-positive neurons and glia in the central nervous system of EGFP transgenic mice. J Comp Neurol 457: 404-419.
57. You Y, Richer EJ, Huang T, Brody SL, (2002) Growth and differentiation of mouse tracheal epithelial cells: selection of a proliferative population. Am J Physiol Lung Cell Mol Physiol 283: L1315-1321.
58. Sorci G, Riuzzi F, Agneletti AL, Marchetti C, Donato R, (2003) S100B inhibits myogenic differentiation and myotube formation in a RAGE-independent manner. Mol Cell Biol 23: 4870-4881.
59. Soderberg O, Gullberg M, Jarvius M, Ridderstrale K, Leuchowius KJ, et al. (2006) Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat Methods 3: 995-1000.